We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$605M
AUM Growth
+$67.9M
Cap. Flow
+$24.1M
Cap. Flow %
3.98%
Top 10 Hldgs %
27.25%
Holding
233
New
21
Increased
108
Reduced
85
Closed
7

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.01M
2
CELG
Celgene Corp
CELG
+$843K
3
MRK icon
Merck
MRK
+$729K
4
MO icon
Altria Group
MO
+$710K
5
BFH icon
Bread Financial
BFH
+$696K

Sector Composition

Rank Sector Weight
1 Technology 14.52%
2 Financials 12.5%
3 Healthcare 11.5%
4 Industrials 9.25%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
101
Vanguard Total Stock Market ETF
VTI
$653B
$1.45M 0.24%
8,885
+2,989
+51% +$468K
ADP icon
102
Automatic Data Processing
ADP
$103B
$1.44M 0.24%
8,462
-279
-3% -$46.2K
CRM icon
103
Salesforce
CRM
$144B
$1.44M 0.24%
+8,641
New +$1.35M
BMY icon
104
Bristol-Myers Squibb
BMY
$128B
$1.42M 0.23%
22,062
+8,205
+59% +$470K
HYD icon
105
VanEck High Yield Muni ETF
HYD
$4.45B
$1.39M 0.23%
21,767
+5,755
+36% +$370K
VEA icon
106
Vanguard FTSE Developed Markets ETF
VEA
$226B
$1.38M 0.23%
31,412
+25,190
+405% +$1.07M
SPTM icon
107
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.29M 0.21%
32,443
+17,138
+112% +$653K
RTN
108
DELISTED
Raytheon Company
RTN
$1.28M 0.21%
5,826
+20
+0.3% +$4.23K
VWO icon
109
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.26M 0.21%
28,417
+8,819
+45% +$374K
MDT icon
110
Medtronic
MDT
$108B
$1.23M 0.2%
10,874
+1,463
+16% +$161K
ATVI
111
DELISTED
Activision Blizzard
ATVI
$1.22M 0.2%
19,886
-4,614
-19% -$255K
SLYG icon
112
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.05B
$1.21M 0.2%
18,713
+507
+3% +$31.3K
VGSH icon
113
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$1.16M 0.19%
19,085
+2
+0% +$122
MMM icon
114
3M
MMM
$91.4B
$1.06M 0.18%
7,219
-1,427
-17% -$200K
ABBV icon
115
AbbVie
ABBV
$457B
$995K 0.16%
11,241
+243
+2% +$20.2K
APD icon
116
Air Products & Chemicals
APD
$65.2B
$988K 0.16%
4,205
+228
+6% +$51.5K
SYK icon
117
Stryker
SYK
$129B
$973K 0.16%
4,637
-295
-6% -$61.2K
CME icon
118
CME Group
CME
$92.6B
$950K 0.16%
4,733
+1
+0% +$205
NFLX icon
119
Netflix
NFLX
$296B
$928K 0.15%
28,690
-2,860
-9% -$84.8K
USB icon
120
US Bancorp
USB
$98.8B
$921K 0.15%
15,541
-2,920
-16% -$169K
WM icon
121
Waste Management
WM
$96B
$908K 0.15%
7,969
+1,891
+31% +$214K
VRSK icon
122
Verisk Analytics
VRSK
$27.3B
$887K 0.15%
5,945
+358
+6% +$53K
LW icon
123
Lamb Weston
LW
$7.19B
$885K 0.15%
+10,290
New +$829K
WFC icon
124
Wells Fargo
WFC
$264B
$840K 0.14%
15,627
-1,561
-9% -$81.8K
AFL icon
125
Aflac
AFL
$64.4B
$805K 0.13%
15,221
+719
+5% +$38.2K

Similar funds

Girard Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Girard Partners held 233 positions worth $605M, up 13% from $537M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Girard Partners deployed $24.1M of net new capital in Q4 2019, opening 21 new positions and adding to 108 existing holdings. Its largest new stake was Salesforce: 8,641 shares worth $1.44M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $2.01M trimmed.

  • Girard Partners's largest Q4 2019 buy was Salesforce: 8,641 shares worth $1.44M.
  • Girard Partners added most to Vanguard Total International Bond ETF in Q4 2019, an estimated $10.8M increase.
  • Girard Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $2.01M.
  • Girard Partners fully exited Celgene Corp in Q4 2019, selling an estimated $843K.
  • Girard Partners's ten largest holdings make up 27% of its $605M portfolio in Q4 2019.
  • Girard Partners opened 21 new positions and closed 7 in Q4 2019.
  • Girard Partners's portfolio value rose 13% quarter-over-quarter to $605M.

Based on Girard Partners's 13F filing for Q4 2019, filed 3 Feb 2020.